161 related articles for article (PubMed ID: 28123058)
1. Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
Katan M; Moon Y; von Eckardstein A; Spanaus K; DeRosa J; Gutierrez J; DeCarli C; Wright C; Sacco R; Elkind M
Stroke; 2017 Mar; 48(3):604-610. PubMed ID: 28123058
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.
Katan M; Moon YP; Paik MC; Mueller B; Huber A; Sacco RL; Elkind MS
Stroke; 2016 Jul; 47(7):1714-9. PubMed ID: 27197849
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
Wright CB; Shah NH; Mendez AJ; DeRosa JT; Yoshita M; Elkind MS; Sacco RL; DeCarli C; Rundek T; Silverberg S; Dong C; Wolf M
Stroke; 2016 Apr; 47(4):923-8. PubMed ID: 26956260
[TBL] [Abstract][Full Text] [Related]
4. Subclinical Cerebrovascular Disease Increases the Risk of Incident Stroke and Mortality: The Northern Manhattan Study.
Wright CB; Dong C; Perez EJ; De Rosa J; Yoshita M; Rundek T; DeCarli C; Gutierrez J; Elkind MSV; Sacco RL
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28847914
[TBL] [Abstract][Full Text] [Related]
5. Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.
De Marchis GM; Schneider J; Weck A; Fluri F; Fladt J; Foerch C; Mueller B; Luft A; Christ-Crain M; Arnold M; Katan M
Neurology; 2018 Feb; 90(6):e455-e465. PubMed ID: 29321236
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
Theilade S; Hansen TW; Goetze JP; Rossing P
Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
[TBL] [Abstract][Full Text] [Related]
7. Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).
Hudson BI; Moon YP; Kalea AZ; Khatri M; Marquez C; Schmidt AM; Paik MC; Yoshita M; Sacco RL; DeCarli C; Wright CB; Elkind MS
Atherosclerosis; 2011 May; 216(1):192-8. PubMed ID: 21316677
[TBL] [Abstract][Full Text] [Related]
8. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
9. Atherosclerotic Plaques in the Aortic Arch and Subclinical Cerebrovascular Disease.
Tugcu A; Jin Z; Homma S; Elkind MS; Rundek T; Yoshita M; DeCarli C; Nakanishi K; Shames S; Wright CB; Sacco RL; Di Tullio MR
Stroke; 2016 Nov; 47(11):2813-2819. PubMed ID: 27729581
[TBL] [Abstract][Full Text] [Related]
10. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP.
Boeck L; Eggimann P; Smyrnios N; Pargger H; Thakkar N; Siegemund M; Marsch S; Rakic J; Tamm M; Stolz D
Eur Respir J; 2011 Mar; 37(3):595-603. PubMed ID: 20530040
[TBL] [Abstract][Full Text] [Related]
11. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
12. Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.
Khaleghi M; Al-Omari MA; Kondragunta V; Morgenthaler NG; Struck J; Bergmann A; Mosley TH; Kullo IJ
Am J Cardiol; 2009 May; 103(9):1255-60. PubMed ID: 19406268
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Exposure to Ambient Air Pollution and Subclinical Cerebrovascular Disease in NOMAS (the Northern Manhattan Study).
Kulick ER; Wellenius GA; Kaufman JD; DeRosa JT; Kinney PL; Cheung YK; Wright CB; Sacco RL; Elkind MS
Stroke; 2017 Jul; 48(7):1966-1968. PubMed ID: 28455324
[TBL] [Abstract][Full Text] [Related]
14. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
Bernasconi M; Tamm M; Bingisser R; Miedinger D; Leuppi J; Müller B; Christ-Crain M; Stolz D
Chest; 2011 Jul; 140(1):91-99. PubMed ID: 21106656
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsia.
Birdir C; Janssen K; Stanescu AD; Enekwe A; Kasimir-Bauer S; Gellhaus A; Kimmig R; Köninger A
Arch Gynecol Obstet; 2015 Nov; 292(5):1033-42. PubMed ID: 25975456
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G
Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease.
Vilar-Bergua A; Riba-Llena I; Penalba A; Cruz LM; Jiménez-Balado J; Montaner J; Delgado P
Neurology; 2016 Dec; 87(24):2533-2539. PubMed ID: 27956564
[TBL] [Abstract][Full Text] [Related]
18. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T;
Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437
[TBL] [Abstract][Full Text] [Related]
20. Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study.
Willey JZ; Moon YP; Paik MC; Yoshita M; Decarli C; Sacco RL; Elkind MS; Wright CB
Neurology; 2011 Jun; 76(24):2112-8. PubMed ID: 21653889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
